MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock
$7,006,982
Proceeds from common
stock option...
$888,282
Proceeds from related
party
$572,865
Net cash provided by
financing activities
$8,175,659
Canceled cashflow
$292,470
Net increase
(decrease) in cash
$3,513,990
Canceled cashflow
$4,661,669
Offering costs
$292,470
Stock-based compensation
expense
$6,313,167
Unrealized loss on
short-term investments
-$35,212
Prepaid expenses
-$26,583
Net cash used in
operating activities
-$4,661,669
Canceled cashflow
$6,374,962
Net loss
-$10,442,485
Trade accounts
payable and accrued...
-$594,146
Back
Back
Cash Flow
source: myfinsight.com
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)